Next-Generation Cancer Diagnostics Market to Reach USD 47.2 Billion By 2033, Driven by Technological Advancements and Personalized Medicine Trends
September 09, 2024 13:34 ET
|
Dimension Market Research
New York, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Cancer Diagnostics Market size is expected to reach USD 19.1 billion by 2024. It is further anticipated to reach a...
Processa Pharmaceuticals Provides Product Pipeline and Financial Update
August 28, 2024 08:00 ET
|
Processa Pharmaceuticals, Inc.
Phase 2 trial with NGC-Cap in breast cancer underway NGC-Cap Phase 1b trial demonstrated a favorable safety profile with preliminary anti-tumor activity Preclinical studies demonstrated NGC-Iri...
NewHydrogen CEO Steve Hill Discusses Training Next Generation of Energy and Climate Tech Entrepreneurs with Executive Director of TEX-E
July 02, 2024 03:30 ET
|
NewHydrogen, Inc.
Mr. David Pruner elaborates on preparing students and future entrepreneurs to solve dual issues of finding more energy for the world and at the same time lowering carbon intensity SANTA CLARITA,...
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
March 25, 2024 08:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Foresight: Rail Vision Reveals its Next Generation AI Computer for Railway Safety and Accident Prevention
January 31, 2024 08:30 ET
|
Foresight Autonomous Holdings Ltd.
The new development offers high performance and real time artificial intelligence deep learning inference Ness Ziona, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd....
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
January 02, 2024 17:06 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook
November 29, 2023 08:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next...
AgEagle Announces DeltaQuad EVO Is First UAV to Fully Integrate RedEdge-P dual High Resolution Multispectral Sensor
September 14, 2023 08:30 ET
|
AgEagle Aerial Systems, Inc.
Represents Ideal Solution for Environmental Monitoring and Conservation Efforts by Commercial and Government Drone Operators WICHITA, Kan., Sept. 14, 2023 (GLOBE NEWSWIRE) -- AgEagle Aerial...
(Corrected) Global Tech Industries Group, Inc. acquires AI Commerce Group, LLC., through a binding Membership Interest Purchase Agreement
August 21, 2023 16:55 ET
|
Global Tech Industries Group, Inc.
New York, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- (GTII: OTC) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that it has signed a Membership Interest...
The Global E-cigarette Market is projected to reach USD 68.84 Billion market size, growing at a CAGR of 19.41% by 2023-28.
May 23, 2023 09:06 ET
|
Bonafide Research & Marketing Pvt. Ltd.
Clifton, New Jersey, May 23, 2023 (GLOBE NEWSWIRE) -- E-cigarettes are often perceived as a less harmful alternative to smoking, which has led health-conscious individuals to switch to vaping....